Free Trial

B. Metzler seel. Sohn & Co. Holding AG Acquires Shares of 377,884 Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background

B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in Colgate-Palmolive (NYSE:CL - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 377,884 shares of the company's stock, valued at approximately $39,228,000.

Other institutional investors have also recently made changes to their positions in the company. Price T Rowe Associates Inc. MD boosted its position in Colgate-Palmolive by 27.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company's stock valued at $3,698,096,000 after buying an additional 8,933,912 shares during the period. Massachusetts Financial Services Co. MA grew its position in shares of Colgate-Palmolive by 40.7% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company's stock worth $870,400,000 after buying an additional 2,593,313 shares during the last quarter. Legal & General Group Plc increased its stake in shares of Colgate-Palmolive by 0.8% during the second quarter. Legal & General Group Plc now owns 7,785,101 shares of the company's stock valued at $755,465,000 after buying an additional 61,413 shares during the period. GUARDCAP ASSET MANAGEMENT Ltd raised its holdings in shares of Colgate-Palmolive by 4.1% during the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 6,987,454 shares of the company's stock valued at $629,220,000 after acquiring an additional 278,150 shares in the last quarter. Finally, Acadian Asset Management LLC lifted its stake in Colgate-Palmolive by 108.4% in the second quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company's stock worth $551,367,000 after acquiring an additional 2,955,442 shares during the period. Hedge funds and other institutional investors own 80.41% of the company's stock.

Analysts Set New Price Targets

CL has been the subject of several research reports. Jefferies Financial Group lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and decreased their price objective for the stock from $103.00 to $95.00 in a report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a "buy" rating to a "hold" rating and raised their target price for the company from $107.00 to $109.00 in a research note on Monday, September 9th. Morgan Stanley upped their price target on Colgate-Palmolive from $103.00 to $111.00 and gave the stock an "overweight" rating in a research note on Monday, July 29th. TD Cowen lowered their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Monday, October 28th. Finally, Hsbc Global Res cut shares of Colgate-Palmolive from a "strong-buy" rating to a "hold" rating in a report on Friday, July 26th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $105.11.

Get Our Latest Research Report on Colgate-Palmolive

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock traded down $1.01 during midday trading on Tuesday, reaching $93.61. 4,918,045 shares of the company traded hands, compared to its average volume of 4,390,670. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a 12 month low of $75.17 and a 12 month high of $109.30. The firm has a market capitalization of $76.48 billion, a price-to-earnings ratio of 27.12, a price-to-earnings-growth ratio of 3.34 and a beta of 0.42. The business has a 50 day moving average of $99.06 and a two-hundred day moving average of $98.55.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a $0.50 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.14%. Colgate-Palmolive's payout ratio is 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In other news, Director Martina Hundmejean sold 2,313 shares of the business's stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now owns 11,755 shares of the company's stock, valued at approximately $1,220,874.30. The trade was a 16.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company's stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.37% of the company's stock.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should you invest $1,000 in Colgate-Palmolive right now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines